Similar to the effect of miR155, an antagomir for miR210 decreased expression of proinflammatory cytokines IL6, TNFα, IL1β, CCL2, and CCL3 reducing the neurological impairment, putting miR210 as potent regulator of inflammation during stroke recovery (Huang et al., 2018). Here, IL6 is linked to stroke disorder.